Mirtazapine for Sleep Disorders in Alzheimer's Disease
NCT01867775 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-06-04
Summary
The purpose of this study is to determine whether mirtazapine is effective in the treatment of sleep disorders in Alzheimers disease.
Conditions
- Alzheimer's Disease
- Sleep Disorders
Interventions
- DRUG
-
Mirtazapine
Mirtazapine 15 mg, at night, once a day for 14 days
Sponsors & Collaborators
-
Brasilia University Hospital
lead OTHER
Principal Investigators
-
Francisca M Scoralick, MD · University of Brasilia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2013-12-31
- Completion
- 2014-05-31
Countries
- Brazil
Study Locations
More Related Trials
-
Therapeutic Effectiveness of Exercise Associated to the Pharmacotherapy in Major Depression
NCT02427789 ·Status: COMPLETED ·Phase: NA
-
Cognition, Sleep, Neurophysiology of Suicidal Depressed Patients
NCT04813835 ·Status: COMPLETED
-
Predictors of the Outcome of Late Life Depression
NCT02441387 ·Status: UNKNOWN
-
Effect of Short-Term Mindfulness-Based Training For Major Depression Disorder: An Eye-Tracking Study
NCT04071886 ·Status: UNKNOWN ·Phase: NA
-
Determining Changes in Brain Structure Associated With Symptoms of Late-life Depression
NCT00178087 ·Status: COMPLETED
-
Apathy in Late Life Depression: New Biomarkers Using Actimetry and Magnetic Resonance Imaging
NCT03807167 ·Status: COMPLETED ·Phase: NA
-
Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics
NCT03219008 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression
NCT02624102 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Cardiac Autonomic Behavior in Patients With Mood Disorders
NCT01272518 ·Status: UNKNOWN
-
Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement
NCT01458626 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Non-drug Therapy on Cognitive Function in Healthy Individuals and Patients With First Episode Depression
NCT04503343 ·Status: COMPLETED ·Phase: NA
-
Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder
NCT02901249 ·Status: COMPLETED ·Phase: PHASE4
-
Sleep Therapy for Insomnia and Depression
NCT02943278 ·Status: COMPLETED ·Phase: NA
-
Treatment Resistant Geriatric Depression in Primary Care
NCT01392287 ·Status: COMPLETED ·Phase: PHASE1
-
Algorithm Guided Treatment Strategies for Major Depressive Disorder
NCT01764867 ·Status: UNKNOWN ·Phase: PHASE4
-
Neural Mechanism Underlying Social Cognition in Depressive Patients
NCT03413670 ·Status: UNKNOWN
-
Behavioral Processes Underlying Reward Processing in Depression
NCT00205933 ·Status: COMPLETED
-
Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery
NCT06454695 ·Status: RECRUITING ·Phase: NA
-
Brain Imaging in Depression
NCT00050700 ·Status: COMPLETED
-
Preventing Depression in Patients With Macular Degeneration
NCT00042211 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive Symptoms
NCT00844974 ·Status: COMPLETED ·Phase: NA
-
Depression and Increased Health Services Utilization Among Elderly Primary Care Patients
NCT00279526 ·Status: COMPLETED
-
A One-year Trajectory of Depression Status Changes in Older Adults With MCI and SD: a Longitudinal Cohort Study
NCT06308627 ·Status: COMPLETED
-
Non-invasive BCI and Application Verification for Depressed People
NCT06417437 ·Status: RECRUITING ·Phase: PHASE4
-
The Effects of Sleep Deprivation on Antidepressant Response
NCT00178074 ·Status: COMPLETED ·Phase: PHASE4